Sleep, Circadian Rhythms, and Lung Cancer

Abstract

Lung cancer is the leading cause of cancer-related mortality worldwide, with the prevalence of the disease continually rising. Therefore, identifying disease-modifying risk factors is critical, with increasing recognition of the impact of sleep quality/sleep disorders. This narrative review summarizes the evidence on the role of five domains of sleep on lung cancer incidence and progression: (i) sleep quality/duration, (ii) sleep disordered breathing, (iii) circadian rhythm disturbances, (iv) sleep-related movement disorders, and (v) personal, environmental, and social factors that modulate each of these associations. Epidemiological evidence supports reduced sleep duration, increased sleep duration, poor sleep quality, insomnia, obstructive sleep apnea, evening chronotype, peripheral limb movements in sleep, and less robustly for night shift work and restless leg syndrome to be associated with increased risk of lung cancer development, with potential impacts on cancer survival outcomes. Proposed mechanisms underlying the biological plausibility of these epidemiological associations are also explored, with common theories relating to immune dysregulation, metabolic alterations, reductions in melatonin, sympathetic overactivation, increased reactive oxygen species, production of protumorigenic exosomes, and inflammation. We also summarized potential treatments addressing impaired sleep quality/sleep disorders and their ability to attenuate the risk of lung cancer and improve cancer survival. Although evidence on reversibility is inconsistent, there are trends toward positive outcomes. Future research should focus on clinical trials to confirm cause and effect relationships, large epidemiologic studies for incidence/prognosis, clarification on the relative efficacy of treatment modalities, and more in vivo animal models to establish the molecular mechanisms underlying these relationships.

Keywords

sleep quality - sleep disorders - lung cancer - cancer survival

Publikationsverlauf

Accepted Manuscript online:
03. Februar 2025

Artikel online veröffentlicht:
17. April 2025

• References

• 1 Metintaş S. Epidemiology of lung cancer. In: Cingi C, Yorgancıoğlu A, Bayar Muluk N, Cruz AA. eds. Airway Diseases. Springer; Cham: 2023
• 2 Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 2023; 20 (09) 624-639
• 3 Fuller PM, Gooley JJ, Saper CB. Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 2006; 21 (06) 482-493
• 4 Assefa SZ, Diaz-Abad M, Wickwire EM, Scharf SM. The functions of sleep. AIMS Neurosci 2015; 2 (03) 155-171
• 5 Medicine Io, Colten HR, Altevogt BM. Institute of Medicine. Committee on Sleep M, Research. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. 1st ed.. Washington, DC: Institute of Medicine: National Academies Press; 2006
• 6 Chaput JP, Dutil C, Sampasa-Kanyinga H. Sleeping hours: what is the ideal number and how does age impact this?. Nat Sci Sleep 2018; 10: 421-430
• 7 Youlden DR, Foresto SA, Aitken JF. Primary malignant lung tumors in children: a report from the Australian Childhood Cancer Registry, 1983-2015. Pediatr Pulmonol 2020; 55 (03) 719-722
• 8 Chaput JP, Dutil C, Featherstone R. et al. Sleep duration and health in adults: an overview of systematic reviews. Appl Physiol Nutr Metab 2020; 45 (10 (Suppl. 2)): S218-S231
• 9 Akberzie W, Kataria L. Sleep disorders and aging in women. Clin Geriatr Med 2021; 37 (04) 667-682
• 10 Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin 2022; 17 (02) 173-191
• 11 Song C, Zhang R, Wang C. et al. Sleep quality and risk of cancer: findings from the English longitudinal study of aging. Sleep 2021; 44 (03) zsaa192
• 12 Ruan GT, Wei YP, Ge YZ. et al. Poor sleep quality association with higher lung cancer risk: a nested case-control study. PeerJ 2023; 11: e16540
• 13 Gottfried T, Kamer I, Salant I. et al. Self-reported sleep quality as prognostic for survival in lung cancer patients. Cancer Manag Res 2020; 12: 313-321
• 14 He Y, Sun LY, Peng KW. et al. Sleep quality, anxiety and depression in advanced lung cancer: patients and caregivers. BMJ Support Palliat Care 2022; 12 (e2): e194-e200
• 15 Soucise A, Vaughn C, Thompson CL. et al. Sleep quality, duration, and breast cancer aggressiveness. Breast Cancer Res Treat 2017; 164 (01) 169-178
• 16 Wiggins EK, Oyekunle T, Howard LE. et al. Sleep quality and prostate cancer aggressiveness: results from the REDUCE trial. Prostate 2020; 80 (15) 1304-1313
• 17 Phipps AI, Bhatti P, Neuhouser ML. et al. Pre-diagnostic sleep duration and sleep quality in relation to subsequent cancer survival. J Clin Sleep Med 2016; 12 (04) 495-503
• 18 Xie J, Zhu M, Ji M. et al. Relationships between sleep traits and lung cancer risk: a prospective cohort study in UK Biobank. Sleep 2021; 44 (09) zsab089
• 19 Zhou T, Wang Z, Qiao C. et al. Sleep disturbances and the risk of lung cancer: a meta-epidemiological study. BMC Cancer 2023; 23 (01) 884
• 20 Yeo BSY, Koh JH, Shi BY. et al. The association between sleep quantity, insomnia and lung cancer risk—a systematic review and meta-analysis. Sleep Breath 2024; 28 (06) 2325-2334
• 21 Wang F, Yang J, Hu S, Bian J, Xu X. The association between sleep duration and lung cancer: a meta-analysis. Sleep Breath 2024; 28 (01) 519-530
• 22 Stone CR, Haig TR, Fiest KM, McNeil J, Brenner DR, Friedenreich CM. The association between sleep duration and cancer-specific mortality: a systematic review and meta-analysis. Cancer Causes Control 2019; 30 (05) 501-525
• 23 Peeri NC, Tao MH, Demissie S, Nguyen UDT. Sleep duration, chronotype, and insomnia and the risk of lung cancer: United Kingdom Biobank cohort. Cancer Epidemiol Biomarkers Prev 2022; 31 (04) 766-774
• 24 Huo Z, Ge F, Li C. et al. Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study. Sleep Med 2021; 87: 183-190
• 25 Shi T, Min M, Sun C, Zhang Y, Liang M, Sun Y. Does insomnia predict a high risk of cancer? A systematic review and meta-analysis of cohort studies. J Sleep Res 2020; 29 (01) e12876
• 26 Yehuda S, Sredni B, Carasso RL, Kenigsbuch-Sredni D. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res 2009; 29 (07) 393-398
• 27 Liu L, Mills PJ, Rissling M. et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 2012; 26 (05) 706-713
• 28 Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 2011; 21 (11) 799-806
• 29 Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 2016; 80 (01) 40-52
• 30 Pine SR, Mechanic LE, Enewold L. et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst 2011; 103 (14) 1112-1122
• 31 Petrov KK, Hayley A, Catchlove S, Savage K, Stough C. Is poor self-rated sleep quality associated with elevated systemic inflammation in healthy older adults?. Mech Ageing Dev 2020; 192: 111388
• 32 Xia L, Zhang P, Niu JW. et al. Relationships between a range of inflammatory biomarkers and subjective sleep quality in chronic insomnia patients: a clinical study. Nat Sci Sleep 2021; 13: 1419-1428
• 33 Fernandez-Mendoza J, Baker JH, Vgontzas AN, Gaines J, Liao D, Bixler EO. Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Brain Behav Immun 2017; 61: 110-116
• 34 Prather AA, Vogelzangs N, Penninx BW. Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). J Psychiatr Res 2015; 60: 95-102
• 35 Aeschbach D, Sher L, Postolache TT, Matthews JR, Jackson MA, Wehr TA. A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 2003; 88 (01) 26-30
• 36 Diethelm K, Libuda L, Bolzenius K, Griefahn B, Buyken AE, Remer T. Longitudinal associations between endogenous melatonin production and reported sleep duration from childhood to early adulthood. Horm Res Paediatr 2010; 74 (06) 390-398
• 37 Riemann D, Klein T, Rodenbeck A. et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 2002; 113 (1-2): 17-27
• 38 Rodenbeck A, Huether G, Rüther E, Hajak G. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders. Adv Exp Med Biol 1999; 467: 89-93
• 39 Ma Z, Yang Y, Fan C. et al. Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget 2016; 7 (29) 46768-46784
• 40 Plaimee P, Weerapreeyakul N, Barusrux S, Johns NP. Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Prolif 2015; 48 (01) 67-77
• 41 Cos S, González A, Güezmes A. et al. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 2006; 118 (02) 274-278
• 42 Irwin M, Mascovich A, Gillin JC, Willoughby R, Pike J, Smith TL. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom Med 1994; 56 (06) 493-498
• 43 Born J, Lange T, Hansen K, Mölle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997; 158 (09) 4454-4464
• 44 Liu X, Chen B, Huang Z. et al. Effects of poor sleep on the immune cell landscape as assessed by single-cell analysis. Commun Biol 2021; 4 (01) 1325
• 45 De Lorenzo BH, de Oliveira Marchioro L, Greco CR, Suchecki D. Sleep-deprivation reduces NK cell number and function mediated by β-adrenergic signalling. Psychoneuroendocrinology 2015; 57: 134-143
• 46 Liu J, Wang R, Tan S, Zhao X, Hou A. Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis. Diabetol Metab Syndr 2024; 16 (01) 63
• 47 Lou P, Chen P, Zhang L. et al. Relation of sleep quality and sleep duration to type 2 diabetes: a population-based cross-sectional survey. BMJ Open 2012; 2 (04) e000956
• 48 Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010; 33 (02) 414-420
• 49 Xi B, He D, Zhang M, Xue J, Zhou D. Short sleep duration predicts risk of metabolic syndrome: a systematic review and meta-analysis. Sleep Med Rev 2014; 18 (04) 293-297
• 50 Hurley S, Goldberg D, Bernstein L, Reynolds P. Sleep duration and cancer risk in women. Cancer Causes Control 2015; 26 (07) 1037-1045
• 51 Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev 2016; 30: 11-24
• 52 Motivala SJ, Tomiyama AJ, Ziegler M, Khandrika S, Irwin MR. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009; 34 (04) 540-545
• 53 Yu D, Zheng W, Johansson M. et al. Overall and central obesity and risk of lung cancer: a pooled analysis. J Natl Cancer Inst 2018; 110 (08) 831-842
• 54 Conte F, De Rosa O, Rescott ML. et al. High sleep fragmentation parallels poor subjective sleep quality during the third wave of the Covid-19 pandemic: an actigraphic study. J Sleep Res 2022; 31 (03) e13519
• 55 Wu D, Tong M, Ji Y. et al. REM sleep fragmentation in patients with short-term insomnia is associated with higher BDI scores. Front Psychiatry 2021; 12: 733998
• 56 Grandner MA, Drummond SP. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007; 11 (05) 341-360
• 57 Cho J, Jo S. Association of obstructive sleep apnea with risk of lung cancer: a nationwide cohort study in Korea. Sci Rep 2024; 14 (01) 12394
• 58 Yoo JE, Han K, Shin DW. et al. Association between changes in alcohol consumption and cancer risk. JAMA Netw Open 2022; 5 (08) e2228544
• 59 Brenner DR, Fehringer G, Zhang ZF. et al. Alcohol consumption and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Cancer Epidemiol 2019; 58: 25-32
• 60 Divani A, Heidari ME, Ghavampour N. et al. Effect of cancer treatment on sleep quality in cancer patients: a systematic review and meta-analysis of Pittsburgh Sleep Quality Index. Support Care Cancer 2022; 30 (06) 4687-4697
• 61 Seo K, Kim JH, Han D. Effects of melatonin supplementation on sleep quality in breast cancer patients: a systematic review and meta-analysis. Healthcare (Basel) 2023; 11 (05) 675
• 62 Jafari-Koulaee A, Bagheri-Nesami M. The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study. Sleep Med 2021; 82: 96-103
• 63 Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003; 35 (01) 12-15
• 64 Hrushesky WJM, Lis CG, Levin RD. et al. Daily evening melatonin prolongs survival among patients with advanced non-small-cell lung cancer. Biol Rhythm Res 2021; 53 (07) 1043-1057
• 65 Seely D, Legacy M, Auer RC. et al. Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): a randomized placebo controlled clinical trial. EClinicalMedicine 2021; 33: 100763
• 66 Garland SN, Xie SX, DuHamel K. et al. Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: a randomized clinical trial. J Natl Cancer Inst 2019; 111 (12) 1323-1331
• 67 Squires LR, Rash JA, Fawcett J, Garland SN. Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors. Sleep Med Rev 2022; 63: 101615
• 68 Gao Y, Liu M, Yao L. et al. Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis. J Evid Based Med 2022; 15 (03) 216-229
• 69 Ma Y, Hall DL, Ngo LH, Liu Q, Bain PA, Yeh GY. Efficacy of cognitive behavioral therapy for insomnia in breast cancer: a meta-analysis. Sleep Med Rev 2021; 55: 101376
• 70 Dean GE, Weiss C, Jungquist CR. et al. Nurse-delivered brief behavioral treatment for insomnia in lung cancer survivors: a pilot RCT. Behav Sleep Med 2020; 18 (06) 774-786
• 71 Takemura N, Cheung DST, Fong DYT. et al. Effectiveness of aerobic exercise and tai chi interventions on sleep quality in patients with advanced lung cancer: a randomized clinical trial. JAMA Oncol 2024; 10 (02) 176-184
• 72 Tang H, Chen L, Wang Y, Zhang Y, Yang N, Yang N. The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy. Support Care Cancer 2021; 29 (12) 7299-7306
• 73 Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA 2020; 323 (14) 1389-1400
• 74 Epstein LJ, Kristo D, Strollo Jr PJ. et al; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5 (03) 263-276
• 75 Yuan F, Hu Y, Xu F, Feng X. A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options. Front Immunol 2024; 15: 1374236
• 76 Kendzerska T, Povitz M, Leung RS. et al. Obstructive sleep apnea and incident cancer: a large retrospective multicenter clinical cohort study. Cancer Epidemiol Biomarkers Prev 2021; 30 (02) 295-304
• 77 Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep 2016; 39 (08) 1493-1500
• 78 Cheong AJY, Tan BKJ, Teo YH. et al. Obstructive sleep apnea and lung cancer: a systematic review and meta-analysis. Ann Am Thorac Soc 2022; 19 (03) 469-475
• 79 Huang HY, Lin SW, Chuang LP. et al. Severe OSA associated with higher risk of mortality in stage III and IV lung cancer. J Clin Sleep Med 2020; 16 (07) 1091-1098
• 80 Wang W, He L, Ouyang C, Chen C, Xu X, Ye X. Key common genes in obstructive sleep apnea and lung cancer are associated with prognosis of lung cancer patients. Int J Gen Med 2021; 14: 5381-5396
• 81 Şahin Duyar S, Akın Kabalak P, Fırat S, Yılmaz Ü, Kızılgöz D, Kavurgacı S. Impact of obstructive sleep apnea risk on prognosis and treatment responses of lung cancer. J Med Palliat Care 2024; 5 (02) 97-104
• 82 Kang HS, Kwon HY, Kim IK. et al. Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer. Sci Rep 2020; 10 (01) 1854
• 83 Martínez-García MA, Oscullo G, Gómez-Olivas JD, Inglés-Azorin M, Mompeán S. Is obstructive sleep apnea a risk factor for lung cancer?—from pathophysiological mechanisms to clinical data. Ann Transl Med 2023; 11 (12) 422
• 84 Cao J, Feng J, Li L, Chen B. Obstructive sleep apnea promotes cancer development and progression: a concise review. Sleep Breath 2015; 19 (02) 453-457
• 85 Ahluwalia A, Tarnawski AS. Critical role of hypoxia sensor—HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012; 19 (01) 90-97
• 86 Cui Z, Ruan Z, Li M. et al. Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages. Int Immunopharmacol 2023; 122: 110652
• 87 Almendros I, Wang Y, Becker L. et al. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med 2014; 189 (05) 593-601
• 88 Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 2005; 167 (03) 627-635
• 89 Tirpe AA, Gulei D, Ciortea SM, Crivii C, Berindan-Neagoe I. Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. Int J Mol Sci 2019; 20 (24) 6140
• 90 Wang J, Tian L, Khan MN. et al. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness. Cancer Lett 2018; 415: 73-85
• 91 Kong X, Zhao Y, Li X, Tao Z, Hou M, Ma H. Overexpression of HIF-2α-dependent NEAT1 promotes the progression of non-small cell lung cancer through miR-101-3p/SOX9/Wnt/β-catenin signal pathway. Cell Physiol Biochem 2019; 52 (03) 368-381
• 92 Hao S, Li F, Jiang P, Gao J. Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness. Cell Mol Biol Lett 2022; 27 (01) 44
• 93 Hao S, Zhu X, Liu Z. et al. Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression. Respir Res 2021; 22 (01) 58
• 94 Liu Y, Lao M, Chen J. et al. Short-term prognostic effects of circulating regulatory T-Cell suppressive function and vascular endothelial growth factor level in patients with non-small cell lung cancer and obstructive sleep apnea. Sleep Med 2020; 70: 88-96
• 95 Shih SC, Claffey KP. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001; 19 (01) 19-34
• 96 Gallego-Martin T, Farré R, Almendros I, Gonzalez-Obeso E, Obeso A. Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice. Eur Respir J 2017; 49 (02) 1602111
• 97 Marhuenda E, Campillo N, Gabasa M. et al. Effects of sustained and intermittent hypoxia on human lung cancer cells. Am J Respir Cell Mol Biol 2019; 61 (04) 540-544
• 98 Torres M, Campillo N, Nonaka PN. et al. Aging reduces intermittent hypoxia-induced lung carcinoma growth in a mouse model of sleep apnea. Am J Respir Crit Care Med 2018; 198 (09) 1234-1236
• 99 Hakim F, Wang Y, Zhang SX. et al. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res 2014; 74 (05) 1329-1337
• 100 Khalyfa A, Almendros I, Gileles-Hillel A. et al. Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation. Oncotarget 2016; 7 (34) 54676-54690
• 101 Almendros I, Khalyfa A, Trzepizur W. et al. Tumor cell malignant properties are enhanced by circulating exosomes in sleep apnea. Chest 2016; 150 (05) 1030-1041
• 102 Zheng J, Almendros I, Wang Y. et al. Reduced NADPH oxidase type 2 activity mediates sleep fragmentation-induced effects on TC1 tumors in mice. OncoImmunology 2015; 4 (02) e976057
• 103 Lee DB, An SY, Pyo SS, Kim J, Kim SW, Yoon DW. Sleep fragmentation accelerates carcinogenesis in a chemical-induced colon cancer model. Int J Mol Sci 2023; 24 (05) 4547
• 104 Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137 (01) 95-101
• 105 Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer 2015; 15 (09) 563-572
• 106 Pavwoski P, Shelgikar AV. Treatment options for obstructive sleep apnea. Neurol Clin Pract 2017; 7 (01) 77-85
• 107 Fleetham J, Ayas N, Bradley D. et al; CTS Sleep Disordered Breathing Committee. Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J 2006; 13 (07) 387-392
• 108 Justeau G, Bailly S, Gervès-Pinquié C. et al; ERMES Study Group. Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy. Eur Respir J 2022; 59 (04) 2101935
• 109 O'Connor-Reina C, Rodriguez Alcala L, Ignacio JM. et al. Risk of cancer in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study. Eur Arch Otorhinolaryngol 2024; 281 (06) 3131-3141
• 110 Gómez-Olivas JD, Campos-Rodriguez F, Nagore E. et al. Role of sleep apnea and long-term CPAP treatment in the prognosis of patients with melanoma: a prospective multicenter study of 443 patients. Chest 2023; 164 (06) 1551-1559
• 111 Gharib SA, Seiger AN, Hayes AL, Mehra R, Patel SR. Treatment of obstructive sleep apnea alters cancer-associated transcriptional signatures in circulating leukocytes. Sleep 2014; 37 (04) 709-714 , 714A–714T
• 112 Hernández-Jiménez E, Cubillos-Zapata C, Toledano V. et al. Monocytes inhibit NK activity via TGF-β in patients with obstructive sleep apnoea. Eur Respir J 2017; 49 (06) 1602456
• 113 Kendzerska T, Leung RS, Boulos MI. et al. An association between positive airway pressure device manufacturer and incident cancer? A secondary data analysis. Am J Respir Crit Care Med 2021; 204 (12) 1484-1488
• 114 Kendzerska T, Pendharkar SR, Talarico R. et al. Association between a recalled positive airway pressure device and incident cancer: a population-based study. Eur Respir J 2024; 64 (05) 2400560
• 115 U.S. Food & Drug Administration. Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines. Accessed at: https://www.fda.gov/medical-devices/respiratory-devices/recalled-philips-ventilators-bipap-machines-and-cpap-machines?utm_medium=email&utm_source=govdelivery
• 116 Justeau G, Gervès-Pinquié C, Jouvenot M. et al; Pays de la Loire Sleep Cohort Study Group. Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea. Eur Respir J 2022; 60 (01) 2200551
• 117 Khalyfa A, Masa JF, Qiao Z. et al. Plasma exosomes in obesity hypoventilation syndrome patients drive lung cancer cell malignant properties: effect of long-term adherent CPAP treatment. Biochim Biophys Acta Mol Basis Dis 2022; 1868 (10) 166479
• 118 Sillah A, Watson NF, Peters U. et al. Sleep problems and risk of cancer incidence and mortality in an older cohort: The Cardiovascular Health Study (CHS). Cancer Epidemiol 2022; 76: 102057
• 119 Chauhan S, Norbury R, Faßbender KC, Ettinger U, Kumari V. Beyond sleep: a multidimensional model of chronotype. Neurosci Biobehav Rev 2023; 148: 105114
• 120 Kendzerska T, Murray BJ, Colelli DR. et al. The relationship between the morningness-eveningness questionnaire and incident cancer: a historical clinical cohort study. Sleep Med 2024; 117: 139-145
• 121 Wirth MD, Burch JB, Hébert JR. et al. Case-control study of breast cancer in India: role of PERIOD3 clock gene length polymorphism and chronotype. Cancer Invest 2014; 32 (07) 321-329
• 122 Molina-Montes E, Rodríguez-Barranco M, Ching-López A. et al. Circadian clock gene variants and their link with chronotype, chrononutrition, sleeping patterns and obesity in the European prospective investigation into cancer and nutrition (EPIC) study. Clin Nutr 2022; 41 (09) 1977-1990
• 123 Tian S, Huangfu L, Ai S. et al. Causal relationships between chronotype and risk of multiple cancers by using longitudinal data and Mendelian randomization analysis. Sci China Life Sci 2023; 66 (10) 2433-2436
• 124 Liu Y, Hao J, Yuan G. et al. PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells. Int J Gen Med 2021; 14: 7077-7087
• 125 Al-Naggar RA, Anil Sh. Artificial light at night and cancer: global study. Asian Pac J Cancer Prev 2016; 17 (10) 4661-4664
• 126 Gooley JJ, Chamberlain K, Smith KA. et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab 2011; 96 (03) E463-E472
• 127 Lawther AJ, Phillips AJK, Chung NC. et al. Disrupting circadian rhythms promotes cancer-induced inflammation in mice. Brain Behav Immun Health 2022; 21: 100428
• 128 Almoosawi S, Vingeliene S, Gachon F. et al. Chronotype: implications for epidemiologic studies on chrono-nutrition and cardiometabolic health. Adv Nutr 2019; 10 (01) 30-42
• 129 Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 2012; 69 (08) 551-556
• 130 Wendeu-Foyet MG, Menegaux F. Circadian disruption and prostate cancer risk: an updated review of epidemiological evidences. Cancer Epidemiol Biomarkers Prev 2017; 26 (07) 985-991
• 131 Cordina-Duverger E, Uchai S, Tvardik N. et al; Welca Study Group. Sleep traits, night shift work and lung cancer risk among women: results from a population-based case-control study in France (The WELCA Study). Int J Environ Res Public Health 2022; 19 (23) 16246
• 132 Schernhammer ES, Feskanich D, Liang G, Han J. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol 2013; 178 (09) 1434-1441
• 133 Wei T, Li C, Heng Y. et al. Association between night-shift work and level of melatonin: systematic review and meta-analysis. Sleep Med 2020; 75: 502-509
• 134 Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol 2008; 4 (08) 436-447
• 135 Carriedo-Diez B, Tosoratto-Venturi JL, Cantón-Manzano C, Wanden-Berghe C, Sanz-Valero J. The effects of the exogenous melatonin on shift work sleep disorder in health personnel: a systematic review. Int J Environ Res Public Health 2022; 19 (16) 10199
• 136 Razavi P, Devore EE, Bajaj A. et al. Shift work, chronotype, and melatonin rhythm in nurses. Cancer Epidemiol Biomarkers Prev 2019; 28 (07) 1177-1186
• 137 Lam C, Chung MH. Dose-response effects of light therapy on sleepiness and circadian phase shift in shift workers: a meta-analysis and moderator analysis. Sci Rep 2021; 11 (01) 11976
• 138 Merlino G, Gigli GL. Sleep-related movement disorders. Neurol Sci 2012; 33 (03) 491-513
• 139 Joseph V, Nagalli S. Periodic Limb Movement Disorder. StatPearls; Treasure Island (FL): 2024
• 140 Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev 2006; 10 (03) 169-177
• 141 Broström A, Alimoradi Z, Lind J, Ulander M, Lundin F, Pakpour A. Worldwide estimation of restless legs syndrome: a systematic review and meta-analysis of prevalence in the general adult population. J Sleep Res 2023; 32 (03) e13783
• 142 Choi JW, Song JS, Lee YJ, Jeong DU. Periodic limb movements in sleep is associated with increased mortality. Psychiatry Investig 2017; 14 (05) 669-673
• 143 Kendzerska T, Kamra M, Murray BJ, Boulos MI. Incident cardiovascular events and death in individuals with restless legs syndrome or periodic limb movements in sleep: a systematic review. Sleep 2017;40(03):
• 144 Kendzerska T, Murray BJ, Gershon AS. et al. Polysomnographic assessment of sleep disturbances in cancer development: a historical multicenter clinical cohort study. Chest 2023; 164 (02) 517-530
• 145 Cubo E, Gallego-Nieto C, Elizari-Roncal M. et al. Is restless legs syndrome associated with an increased risk of mortality? A meta-analysis of cohort studies. Tremor Other Hyperkinet Mov (N Y) 2019; 9
• 146 Fuhs A, Bentama D, Hoffmann W. et al. Restless legs syndrome and cancer: an analysis in three independent studies. Epidemiol Rev 2014; 2: 4
• 147 Wu MN, Lai CL, Liu CK. et al. Basal sympathetic predominance in periodic limb movements in sleep with obstructive sleep apnea. J Sleep Res 2015; 24 (06) 722-729
• 148 Jin B, Wang A, Earley C, Allen R. Moderate to severe but not mild RLS is associated with greater sleep-related sympathetic autonomic activation than healthy adults without RLS. Sleep Med 2020; 68: 89-95
• 149 Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn) 2021; 25 (01) 45-52
• 150 Sun Y, Li Z, Li J, Li Z, Han J. A healthy dietary pattern reduces lung cancer risk: a systematic review and meta-analysis. Nutrients 2016; 8 (03) 134
• 151 Zuraikat FM, St-Onge MP, Makarem N, Boege HL, Xi H, Aggarwal B. Evening chronotype is associated with poorer habitual diet in US women, with dietary energy density mediating a relation of chronotype with cardiovascular health. J Nutr 2021; 151 (05) 1150-1158
• 152 Khan MK, Chu YL, Kirk SF, Veugelers PJ. Are sleep duration and sleep quality associated with diet quality, physical activity, and body weight status? A population-based study of Canadian children. Can J Public Health 2015; 106 (05) e277-e282
• 153 Godos J, Grosso G, Castellano S, Galvano F, Caraci F, Ferri R. Association between diet and sleep quality: a systematic review. Sleep Med Rev 2021; 57: 101430
• 154 Liu Y, Tabung FK, Stampfer MJ, Redline S, Huang T. Overall diet quality and proinflammatory diet in relation to risk of obstructive sleep apnea in 3 prospective US cohorts. Am J Clin Nutr 2022; 116 (06) 1738-1747
• 155 Krističević T, Štefan L, Sporiš G. The associations between sleep duration and sleep quality with body-mass index in a large sample of young adults. Int J Environ Res Public Health 2018; 15 (04) 758
• 156 Shah N, Roux F. The relationship of obesity and obstructive sleep apnea. Clin Chest Med 2009; 30 (03) 455-465 , vii
• 157 Arora T, Taheri S. Associations among late chronotype, body mass index and dietary behaviors in young adolescents. Int J Obes (Lond) 2015; 39 (01) 39-44
• 158 Manenschijn L, van Kruysbergen RG, de Jong FH, Koper JW, van Rossum EF. Shift work at young age is associated with elevated long-term cortisol levels and body mass index. J Clin Endocrinol Metab 2011; 96 (11) E1862-E1865
• 159 Huang YP, Chien WC, Chung CH. et al. Increased incidence of alcohol use disorder and alcohol-related psychiatric disorders in patients with obstructive sleep apnea: a nationwide population-based cohort study. Sleep Med 2023; 101: 197-204
• 160 Chaput JP, McNeil J, Després JP, Bouchard C, Tremblay A. Short sleep duration is associated with greater alcohol consumption in adults. Appetite 2012; 59 (03) 650-655
• 161 Hug E, Winzeler K, Pfaltz MC, Cajochen C, Bader K. Later chronotype is associated with higher alcohol consumption and more adverse childhood experiences in young healthy women. Clocks Sleep 2019; 1 (01) 126-139
• 162 Wang YH, Li JQ, Shi JF. et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry 2020; 25 (07) 1487-1499
• 163 Wang S, Li B, Wu Y. et al. Relationship of sleep duration with sociodemographic characteristics, lifestyle, mental health, and chronic diseases in a large Chinese adult population. J Clin Sleep Med 2017; 13 (03) 377-384
• 164 Stubbs B, Vancampfort D, Veronese N. et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord 2016; 197: 259-267
• 165 Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010; 24 (02) 89-98
• 166 Au J, Reece J. The relationship between chronotype and depressive symptoms: a meta-analysis. J Affect Disord 2017; 218: 93-104
• 167 Hovanec J, Siemiatycki J, Conway DI. et al. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PLoS One 2018; 13 (02) e0192999
• 168 Guglielmi O, Lanteri P, Garbarino S. Association between socioeconomic status, belonging to an ethnic minority and obstructive sleep apnea: a systematic review of the literature. Sleep Med 2019; 57: 100-106
• 169 Xiao Q, Hale L. Neighborhood socioeconomic status, sleep duration, and napping in middle-to-old aged US men and women. Sleep 2018; 41 (07) zsy076
• 170 Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2012; 16 (04) 987-1007
• 171 Hale L, Troxel W, Buysse DJ. Sleep health: an opportunity for public health to address health equity. Annu Rev Public Health 2020; 41: 81-99